KING THOMAS BRAXTON

CIK 00012793095 companiesMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001279309

Recent Transactions

50 trades

Exercise/Conversion
ACHIEVE LIFE SCIENCES, INC.$ACHV
Performance Restricted Stock Unit (PRSU)
2025-09-04−455,000→ 0 total
Sale
ACHIEVE LIFE SCIENCES, INC.$ACHV
Common Stock
2025-09-04$2.77/sh−139,858→ 315,142 total
Exercise/Conversion
ACHIEVE LIFE SCIENCES, INC.$ACHV
Common Stock
2025-09-04+455,000→ 455,000 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2025-06-06+31,500→ 31,500 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2025-01-13+195,000→ 195,000 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Performance Restricted Stock Unit (PRSU)
2025-01-13+455,000→ 455,000 total
Award
TFF Pharmaceuticals, Inc.
Common Stock
2024-07-03+1,583→ 1,583 total
Award
TFF Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2024-07-03+1,583→ 1,583 total
Award
TFF Pharmaceuticals, Inc.
Restricted stock units
2024-04-18+3,110→ 3,110 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2024-01-22+31,500→ 31,500 total
Award
TFF Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2023-12-13+132,442→ 132,442 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−14,893→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−12,765→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−10,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−30,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−20,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−12,765→ 0 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2023-03-29+23,250→ 23,250 total
Award
ACHIEVE LIFE SCIENCES, INC.$ACHV
Stock Option (right to buy)
2023-03-29+24,000→ 24,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+30,000→ 30,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-12-03+20,000→ 20,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-06-12+10,000→ 10,000 total
Award
VIVUS INC
Non-Qualified Stock Option (Right to Buy)
2020-02-20+15,000→ 15,000 total
Award
VIVUS INC
Non-Qualified Stock Option (Right to Buy)
2018-10-26+15,000→ 15,000 total
Award
VIVUS INC
Employee Stock Option (right to buy)
2018-06-15+200,000→ 200,000 total
Award
VIVUS INC
Employee Stock Option (right to buy)
2018-01-26+600,000→ 600,000 total
Award
VIVUS INC
Employee Stock Option (right to buy)
2017-07-27+125,000→ 125,000 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−33,449→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−19,576→ 0 total
Disposition from Tender
Alexza Pharmaceuticals Inc.
Common Stock
2016-06-21−37,224→ 0 total
Disposition from Tender
Alexza Pharmaceuticals Inc.
Common Stock
2016-06-21−40,000→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−9,921→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−5,453→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Common Stock Warrant (right to buy)
2016-06-21−5,818.969→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−400,000→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−50,001→ 0 total
Disposition to Issuer
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2016-06-21−50,000→ 0 total
Award
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2015-07-22+400,000→ 400,000 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-26$4.49/sh+2,420→ 215,000 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-26$4.49/sh+2,420→ 215,000 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-25$4.50/sh+12,580→ 212,580 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-25$4.50/sh+12,580→ 212,580 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-24$4.48/sh+25,000→ 200,000 total
Purchase
Alexza Pharmaceuticals Inc.
Common Stock
2013-07-24$4.48/sh+25,000→ 200,000 total
Award
Alexza Pharmaceuticals Inc.
Stock Option (right to buy)
2013-03-29+350,000→ 350,000 total
Award
Alexza Pharmaceuticals Inc.
Common Stock
2013-03-29$4.42/sh+175,000→ 175,000 total
Gift
Alexza Pharmaceuticals Inc.
Common Stock
2013-02-25−9,113→ 0 total
Gift
Alexza Pharmaceuticals Inc.
Common Stock
2013-02-25+9,113→ 30,149 total
Sale
Alexza Pharmaceuticals Inc.
Common Stock
2012-08-27$4.14/sh−10,000→ 10,229 total
Gift
Alexza Pharmaceuticals Inc.
Common Stock
2012-08-14−1,116→ 9,113 total

Companies

Recent Filings

Address

ALEXZA PHARMACEUTICALS INC. 2091 STIERLIN COURT

MOUNTAIN VIEW, CA, 94043

View on SEC.gov